ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 29 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398 | -6.4% | 437,528 | -2.7% | 0.00% | 0.0% |
| Q2 2023 | $425 | +16.8% | 449,733 | +18.3% | 0.00% | – |
| Q1 2023 | $364 | -16.5% | 380,233 | -21.6% | 0.00% | -100.0% |
| Q4 2022 | $436 | -99.8% | 484,733 | +498.2% | 0.00% | – |
| Q3 2022 | $183,000 | -16.8% | 81,033 | -7.1% | 0.00% | – |
| Q2 2022 | $220,000 | +144.4% | 87,233 | +185.7% | 0.00% | – |
| Q1 2022 | $90,000 | -29.7% | 30,533 | +19.6% | 0.00% | – |
| Q4 2021 | $128,000 | – | 25,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
| Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
| Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
| Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
| Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
| Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
| XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
| Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
| Renaissance Technologies | 437,528 | $398 | 0.00% |
| JPMORGAN CHASE & CO | 989 | $900 | 0.00% |